Related references
Note: Only part of the references are listed.Ulcerative Colitis-associated Colorectal Cancer Shows a Poorer Survival than sporadic colorectal cancer: A Nationwide Japanese Study
Toshiaki Watanabe et al.
INFLAMMATORY BOWEL DISEASES (2011)
Translational Mini-Review Series on Th17 Cells: Are T helper 17 cells really pathogenic in autoimmunity?
M. I. Koenders et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
SMAD2 Is Essential for TGFβ-mediated Th17 Cell Generation
Nidhi Malhotra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells
Xinming Su et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-17 Promotes Tumor Development through the Induction of Tumor Promoting Microenvironments at Tumor Sites and Myeloid-Derived Suppressor Cells
Donggou He et al.
JOURNAL OF IMMUNOLOGY (2010)
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis
Wook-Jin Chae et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Nonsteroidal Antiinflammatory Drugs and Cyclooxygenase Inhibition in the Gastrointestinal Tract: A Trip From Peptic Ulcer to Colon Cancer
Angel Lanas
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)
Endogenous IL-17 contributes to reduced tumor growth and metastasis
Ilona Kryczek et al.
BLOOD (2009)
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
Ilona Kryczek et al.
BLOOD (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Low Levels of Tumor Necrosis Factor alpha increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site
Bin Li et al.
CANCER RESEARCH (2009)
Inflammation and colorectal cancer
Sarah Kraus et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
S. Brand
GUT (2009)
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Natalia Martin-Orozco et al.
IMMUNITY (2009)
InterIeukin-23/Th17 Pathways and Inflammatory Bowel Disease
Clara Abraham et al.
INFLAMMATORY BOWEL DISEASES (2009)
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway
Lin Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
A protective function for interleukin 17A in T cell-mediated intestinal inflammation
William O'Connor et al.
NATURE IMMUNOLOGY (2009)
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses
Shaoguang Wu et al.
NATURE MEDICINE (2009)
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer
Linda A. Feagins et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice
Reiko Ito et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease
Masayuki Fukata et al.
JOURNAL OF IMMUNOLOGY (2008)
Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies
Peter Laszlo Lakatos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment
Ilona Kryczek et al.
JOURNAL OF IMMUNOLOGY (2007)
Sequence variants in toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk
JL Sun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Convergence of Wnt, β-catenin, and cadherin pathways
WJ Nelson et al.
SCIENCE (2004)
Interleukin-17 promotes angiogenesis and tumor growth
M Numasaki et al.
BLOOD (2003)
Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development
S Sturlan et al.
CARCINOGENESIS (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
EM El-Omar et al.
NATURE (2000)
Share Paper
